Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Immucell (ICCC) Return on Invested Capital (2016 - 2025)

Immucell (ICCC) has disclosed Return on Invested Capital for 15 consecutive years, with 0.07% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Invested Capital changed 0.0% year-over-year to 0.07%, compared with a TTM value of 0.07% through Sep 2025, changed 0.0%, and an annual FY2024 reading of 0.06%, down 2.0% over the prior year.
  • Return on Invested Capital was 0.07% for Q3 2025 at Immucell, up from 0.05% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.07% in Q3 2025 and bottomed at 0.2% in Q2 2023.
  • Average Return on Invested Capital over 5 years is 0.03%, with a median of 0.01% recorded in 2025.
  • The sharpest move saw Return on Invested Capital dropped -21bps in 2023, then grew 26bps in 2024.
  • Year by year, Return on Invested Capital stood at 0.01% in 2021, then tumbled by -919bps to 0.07% in 2022, then surged by 91bps to 0.01% in 2023, then plummeted by -663bps to 0.05% in 2024, then soared by 235bps to 0.07% in 2025.
  • Business Quant data shows Return on Invested Capital for ICCC at 0.07% in Q3 2025, 0.05% in Q2 2025, and 0.01% in Q1 2025.